Oxaliplatin - A 10-year trajectory

Shingo Kanaji, Eiji Oki, Hiroshi Saeki, Hiroyuki Kitao, Yoshihiko Maehara, Yoshihiro Kakeji

研究成果: Contribution to journalReview article査読

抄録

Oxaliplatin (Elplat® iv infusion solution) is a third-generation 1,2-DACH-platinum derivative. A number of international clinical trials have investigated the effects of this drug for each of its four indications. Building on the results of these earlier studies, much research has also been carried out in Japan in terms of developing and accumulating evidence on oxaliplatin. This report reviews the trajectory of its use over the last 10-years and considers its future potential.

本文言語英語
ページ(範囲)715-722
ページ数8
ジャーナルJapanese Journal of Cancer and Chemotherapy
43
6
出版ステータス出版済み - 6 2016

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント 「Oxaliplatin - A 10-year trajectory」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル